João Ferreira Reis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
João Ferreira Reis has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Rui Cruz Ferreira
Departamento de Cardiologia - Hospital de Santa Marta - Centro Hospitalar Universitário de Lisboa Central, Lisboa - Portugal
7 shared publicationsAna Teresa Timóteo
Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal
3 shared publicationsDuarte Cacela
Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal
3 shared publicationsRita Ilhão Moreira
Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal
3 shared publicationsAntónio Valentim Gonçalves
Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal
2 shared publicationsCatarina Correia
Departamento de Cardiologia - Hospital de Santa Marta - Centro Hospitalar Universitário de Lisboa Central, Lisboa - Portugal
2 shared publications
Latest Publications
- Open Access
- 22 February 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (5) , 413-420
Coronary sinus Reducer device for the treatment of refractory angina: A multicenter initial experience
- 22 February 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (5) , 413-420
Open AccessCoronary sinus Reducer device for the treatment of refractory angina: A multicenter initial experience
- Open Access
- 13 February 2023
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 120 (2) , e20220205
Tratamento Ambulatorial de Levosimedana por 6 Horas como Ponte para Transplante Cardíaco
Resumo Registro observacional que inclui 8 pacientes consecutivos que aguardavam um transplante cardíaco e necessitaram de terapia inotrópica permanente ou regular (INTERMACS classe 3 ou 4) entre 2018 e 2021. Levosimedana foi administrado em infusão intravenosa de 6 horas (0,2μg/kg/min) a cada 2 semanas em ambiente ambulatorial. O tratamento foi continuado até que um doador estivesse disponível, ou a melhora clínica o tornasse desnecessário. O seguimento médio foi de 4,1±3,5 meses, e nenhum paciente necessitou de outra internação enquanto aguardava [...] Resumo Registro observacional que inclui 8 pacientes consecutivos que aguardavam um transplante cardíaco e necessitaram de terapia inotrópica permanente ou regular (INTERMACS classe 3 ou 4) entre 2018 e 2021. Levosimedana foi administrado em infusão intravenosa de 6 horas (0,2μg/kg/min) a cada 2 semanas em ambiente ambulatorial. O tratamento foi continuado até que um doador estivesse disponível, ou a melhora clínica o tornasse desnecessário. O seguimento médio foi de 4,1±3,5 meses, e nenhum paciente necessitou de outra internação enquanto aguardava
- 13 February 2023
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 120 (2) , e20220205
Open AccessTratamento Ambulatorial de Levosimedana por 6 Horas como Ponte para Transplante Cardíaco
Resumo Registro observacional que inclui 8 pacientes consecutivos que aguardavam um transplante cardíaco e necessitaram de terapia inotrópica permanente ou regular (INTERMACS classe 3 ou 4) entre 2018 e 2021. Levosimedana foi administrado em infusão intravenosa de 6 horas (0,2μg/kg/min) a cada 2 semanas em ambiente ambulatorial. O tratamento foi continuado até que um doador estivesse disponível, ou a melhora clínica o tornasse desnecessário. O seguimento médio foi de 4,1±3,5 meses, e nenhum paciente necessitou de outra internação enquanto aguardava [...] Resumo Registro observacional que inclui 8 pacientes consecutivos que aguardavam um transplante cardíaco e necessitaram de terapia inotrópica permanente ou regular (INTERMACS classe 3 ou 4) entre 2018 e 2021. Levosimedana foi administrado em infusão intravenosa de 6 horas (0,2μg/kg/min) a cada 2 semanas em ambiente ambulatorial. O tratamento foi continuado até que um doador estivesse disponível, ou a melhora clínica o tornasse desnecessário. O seguimento médio foi de 4,1±3,5 meses, e nenhum paciente necessitou de outra internação enquanto aguardava
- Open Access
- 9 January 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (4) , 335-343
Levosimendan in outpatients with advanced heart failure: Single-center experience of 200 intermittent perfusions
- 9 January 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (4) , 335-343
Open AccessLevosimendan in outpatients with advanced heart failure: Single-center experience of 200 intermittent perfusions
- Open Access
- 5 January 2023
- Published by Wiley in Case Reports in Cardiology
- Vol. 2023, 1-4
Ventricular Septal Rupture—The Resurgence of a Post-Myocardial Infarction Dreadful Complication during COVID-19 Pandemic
In the midst of the coronavirus disease-2019 (COVID-19) pandemic, an 84-year-old female patient was admitted due to non-exertional syncope preceded by retrosternal pain. She had experienced a prolonged episode of oppressive chest pain 6 days before her presentation, but due to the concern of contracting COVID-19, she did not present for medical care. Upon admission to the emergency department, the patient was in circulatory shock, with her physical examination being remarkable for the presence of a holosystolic murmur. Admission electrocardiogram revealed an inferior ST-segment elevation with Q waves with extension to the posterior wall, consistent with subacute infarct in the right coronary artery (RCA) territory, and the patient was transferred for primary percutaneous coronary intervention. Upon arrival to the catheterization laboratory, a summary transthoracic echocardiogram was performed, which revealed inferior wall and infero-septal akinesia with an 18 mm ventricular septal rupture. Coronary angiography documented occlusion of the proximal segment of a dominant RCA. Due to a high perioperative risk, the patient underwent successful retrograde percutaneous closure with a 24 mm MemoPart™ device, with mild to moderate residual shunt. Despite an immediate clinical improvement, the patient died 12 hours after the procedure due to refractory cardiogenic shock.
- 5 January 2023
- Published by Wiley in Case Reports in Cardiology
- Vol. 2023, 1-4
Open AccessVentricular Septal Rupture—The Resurgence of a Post-Myocardial Infarction Dreadful Complication during COVID-19 Pandemic
In the midst of the coronavirus disease-2019 (COVID-19) pandemic, an 84-year-old female patient was admitted due to non-exertional syncope preceded by retrosternal pain. She had experienced a prolonged episode of oppressive chest pain 6 days before her presentation, but due to the concern of contracting COVID-19, she did not present for medical care. Upon admission to the emergency department, the patient was in circulatory shock, with her physical examination being remarkable for the presence of a holosystolic murmur. Admission electrocardiogram revealed an inferior ST-segment elevation with Q waves with extension to the posterior wall, consistent with subacute infarct in the right coronary artery (RCA) territory, and the patient was transferred for primary percutaneous coronary intervention. Upon arrival to the catheterization laboratory, a summary transthoracic echocardiogram was performed, which revealed inferior wall and infero-septal akinesia with an 18 mm ventricular septal rupture. Coronary angiography documented occlusion of the proximal segment of a dominant RCA. Due to a high perioperative risk, the patient underwent successful retrograde percutaneous closure with a 24 mm MemoPart™ device, with mild to moderate residual shunt. Despite an immediate clinical improvement, the patient died 12 hours after the procedure due to refractory cardiogenic shock.
- 1 September 2022
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 63 (5) , 614-623
Contemporary prevalence of coronary artery disease in patients referred for heart valve surgery
Article: Contemporary prevalence of coronary artery disease in patients referred for heart valve surgery - The Journal of Cardiovascular Surgery 2022 Jun 22 - Minerva Medica - Journals
- 1 September 2022
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 63 (5) , 614-623
Contemporary prevalence of coronary artery disease in patients referred for heart valve surgery
Article: Contemporary prevalence of coronary artery disease in patients referred for heart valve surgery - The Journal of Cardiovascular Surgery 2022 Jun 22 - Minerva Medica - Journals
- Open Access
- 13 July 2022
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 119 (3) , 413-422
Capacidade Preditiva dos Parâmetros do Teste de Esforço Cardiopulmonar em Pacientes com Insuficiência Cardíaca em Terapia de Ressincronização Cardíaca
Resumo Fundamento Há evidências sugerindo que um corte do pico de consumo de oxigênio (pVO2) de 10ml/kg/min fornece uma estratificação de risco mais precisa em pacientes com Terapia de Ressincronização Cardíaca (TRC). Objetivo Comparar o poder prognóstico de vários parâmetros do teste cardiopulmonar de exercício (TCPE) nesta população e avaliar a capacidade discriminativa dos valores de corte de pVO2 recomendados pelas diretrizes. Métodos Avaliação prospectiva de uma série consecutiva de pacientes com insuficiência cardíaca (IC) com fração de ejeção do [...] Resumo Fundamento Há evidências sugerindo que um corte do pico de consumo de oxigênio (pVO2) de 10ml/kg/min fornece uma estratificação de risco mais precisa em pacientes com Terapia de Ressincronização Cardíaca (TRC). Objetivo Comparar o poder prognóstico de vários parâmetros do teste cardiopulmonar de exercício (TCPE) nesta população e avaliar a capacidade discriminativa dos valores de corte de pVO2 recomendados pelas diretrizes. Métodos Avaliação prospectiva de uma série consecutiva de pacientes com insuficiência cardíaca (IC) com fração de ejeção do
- 13 July 2022
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 119 (3) , 413-422
Open AccessCapacidade Preditiva dos Parâmetros do Teste de Esforço Cardiopulmonar em Pacientes com Insuficiência Cardíaca em Terapia de Ressincronização Cardíaca
Resumo Fundamento Há evidências sugerindo que um corte do pico de consumo de oxigênio (pVO2) de 10ml/kg/min fornece uma estratificação de risco mais precisa em pacientes com Terapia de Ressincronização Cardíaca (TRC). Objetivo Comparar o poder prognóstico de vários parâmetros do teste cardiopulmonar de exercício (TCPE) nesta população e avaliar a capacidade discriminativa dos valores de corte de pVO2 recomendados pelas diretrizes. Métodos Avaliação prospectiva de uma série consecutiva de pacientes com insuficiência cardíaca (IC) com fração de ejeção do [...] Resumo Fundamento Há evidências sugerindo que um corte do pico de consumo de oxigênio (pVO2) de 10ml/kg/min fornece uma estratificação de risco mais precisa em pacientes com Terapia de Ressincronização Cardíaca (TRC). Objetivo Comparar o poder prognóstico de vários parâmetros do teste cardiopulmonar de exercício (TCPE) nesta população e avaliar a capacidade discriminativa dos valores de corte de pVO2 recomendados pelas diretrizes. Métodos Avaliação prospectiva de uma série consecutiva de pacientes com insuficiência cardíaca (IC) com fração de ejeção do
- Open Access
- 12 July 2022
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 41 (9) , 751-758
The prognostic value of the cardiorespiratory optimal point during submaximal exercise testing in heart failure
- 12 July 2022
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 41 (9) , 751-758
Open AccessThe prognostic value of the cardiorespiratory optimal point during submaximal exercise testing in heart failure
- Open Access
- 20 April 2022
- Published by Wiley in Case Reports in Cardiology
- Vol. 2022, 1-4
Percutaneous Closure of Patent Foramen Ovale after Anterior Spinal Cord Infarction
In patients with a patent foramen ovale (PFO) who have had a cryptogenic ischemic stroke, percutaneous closure reduces its recurrence risk. However, its role in spinal cord infarction (SCI) is less well-established. A few case reports describe the putative causative role of PFO in SCI. We present a case of a teenager with cryptogenic anterior SCI in the setting of a deep vein thrombosis and a high risk-PFO who underwent successful percutaneous closure.
- 20 April 2022
- Published by Wiley in Case Reports in Cardiology
- Vol. 2022, 1-4
Open AccessPercutaneous Closure of Patent Foramen Ovale after Anterior Spinal Cord Infarction
In patients with a patent foramen ovale (PFO) who have had a cryptogenic ischemic stroke, percutaneous closure reduces its recurrence risk. However, its role in spinal cord infarction (SCI) is less well-established. A few case reports describe the putative causative role of PFO in SCI. We present a case of a teenager with cryptogenic anterior SCI in the setting of a deep vein thrombosis and a high risk-PFO who underwent successful percutaneous closure.
- 28 February 2022
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 38 (4) , 883-893
Cardiac computed tomographic angiography after abnormal ischemia test as a gatekeeper to invasive coronary angiography
This study aimed to determine the impact of systematic coronary computed tomographic angiography (CCTA) use following an abnormal non-invasive ischemia test (NIST) on patient selection strategy for invasive coronary angiography (ICA). In patients with suspected stable coronary artery disease (CAD), NIST use frequently results in sub-optimal diagnostic and revascularization yields of ICA. This randomized clinical trial, conducted at a single academic tertiary center, selected 220 symptomatic patients with mild-to-moderately abnormal NIST results who were referred for ICA. Patients received either the originally intended ICA (n = 105) or CCTA (n = 115). The primary endpoint was the diagnostic yield of ICA in each group. Revascularization yield and major adverse cardiovascular events at 12 months were also assessed. The patients were 69 ± 9 years old, 60% were men, and 31% had typical angina. Mean pre-test probability of obstructive CAD was 34%. Overall prevalence of obstructive CAD was 37.7% on the index angiographic procedure. In the CCTA group, ICA was cancelled by referring physicians in 83 patients (72.2%) after receiving CCTA results. For those undergoing ICA, diagnostic (84.4% vs. 41.7%, pp = 0.001) yields were significantly higher for CCTA-guided ICA than for standard NIST-guided ICA. Mean cumulative radiation exposure was significantly lower in the CCTA-guided ICA arm than in the NIST-guided ICA arm (12 ± 9 vs. 16 ± 10 mSv, respectively, p = 0.024). There were no significant differences in the primary safety endpoint rates between the strategies (p = 0.439). In patients with suspected CAD and mild-to-moderately abnormal ischemia tests, a diagnostic strategy including CCTA as a gatekeeper is safe and effective and significantly improves diagnostic and revascularization yields of ICA.
- 28 February 2022
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 38 (4) , 883-893
Cardiac computed tomographic angiography after abnormal ischemia test as a gatekeeper to invasive coronary angiography
This study aimed to determine the impact of systematic coronary computed tomographic angiography (CCTA) use following an abnormal non-invasive ischemia test (NIST) on patient selection strategy for invasive coronary angiography (ICA). In patients with suspected stable coronary artery disease (CAD), NIST use frequently results in sub-optimal diagnostic and revascularization yields of ICA. This randomized clinical trial, conducted at a single academic tertiary center, selected 220 symptomatic patients with mild-to-moderately abnormal NIST results who were referred for ICA. Patients received either the originally intended ICA (n = 105) or CCTA (n = 115). The primary endpoint was the diagnostic yield of ICA in each group. Revascularization yield and major adverse cardiovascular events at 12 months were also assessed. The patients were 69 ± 9 years old, 60% were men, and 31% had typical angina. Mean pre-test probability of obstructive CAD was 34%. Overall prevalence of obstructive CAD was 37.7% on the index angiographic procedure. In the CCTA group, ICA was cancelled by referring physicians in 83 patients (72.2%) after receiving CCTA results. For those undergoing ICA, diagnostic (84.4% vs. 41.7%, pp = 0.001) yields were significantly higher for CCTA-guided ICA than for standard NIST-guided ICA. Mean cumulative radiation exposure was significantly lower in the CCTA-guided ICA arm than in the NIST-guided ICA arm (12 ± 9 vs. 16 ± 10 mSv, respectively, p = 0.024). There were no significant differences in the primary safety endpoint rates between the strategies (p = 0.439). In patients with suspected CAD and mild-to-moderately abnormal ischemia tests, a diagnostic strategy including CCTA as a gatekeeper is safe and effective and significantly improves diagnostic and revascularization yields of ICA.
- 1 January 2022
- Vol. 12 (2) , 92-101
Long term follow-up of Marfan Syndrome - experience o an adult congenital heart disease centre
Background: Marfan Syndrome (MFS) is one of the most common connective tissue disorders. The aim of this study was to characterize an adult population with MFS and evaluate its long term prognosis. Methods: A retrospective analysis of adult patients with MFS followed up during the past 40 years in a tertiary congenital heart disease outpatient clinic was performed. Survival analysis was performed according to different parameters, and survival curves were compared using the log-rank test. Results: A total of 62 MFS patients were followed up for a mean period of 12 years (47% male; mean age, 39 years). The baseline mean aortic root diameter (ARD) at the Valsalva sinus was 42.4 +/- 10.3 mm, with 15% of patients having moderate-to-severe aortic regurgitation and seven patients with acute aortic syndrome. The Bentall procedure was the most commonly performed surgical technique, and five patients required re-operation. Of the 17 pregnancies, 29% developed fetal complications; however, there was no maternal morbidity or mortality. A total of ten deaths occurred at a mean age of 52 years. Patients with an ARD <= 45 mm had a significantly lower all-cause mortality rate than patients with 45 < ARD <= 50 mm or with ARD > 50 mm (P = 0.004 and P < 0.001, respectively). Heart failure symptoms were associated with a worse outcome (P = 0.041), while the presence of extracardiac involvement had a protective effect (P < 0.001). Conclusion: MFS-related aortopathy is associated with high morbidity rates. In the overall population, an ARD > 45 mm at the time of diagnosis was associated with higher mortality during follow-up.
- 1 January 2022
- Vol. 12 (2) , 92-101
Long term follow-up of Marfan Syndrome - experience o an adult congenital heart disease centre
Background: Marfan Syndrome (MFS) is one of the most common connective tissue disorders. The aim of this study was to characterize an adult population with MFS and evaluate its long term prognosis. Methods: A retrospective analysis of adult patients with MFS followed up during the past 40 years in a tertiary congenital heart disease outpatient clinic was performed. Survival analysis was performed according to different parameters, and survival curves were compared using the log-rank test. Results: A total of 62 MFS patients were followed up for a mean period of 12 years (47% male; mean age, 39 years). The baseline mean aortic root diameter (ARD) at the Valsalva sinus was 42.4 +/- 10.3 mm, with 15% of patients having moderate-to-severe aortic regurgitation and seven patients with acute aortic syndrome. The Bentall procedure was the most commonly performed surgical technique, and five patients required re-operation. Of the 17 pregnancies, 29% developed fetal complications; however, there was no maternal morbidity or mortality. A total of ten deaths occurred at a mean age of 52 years. Patients with an ARD <= 45 mm had a significantly lower all-cause mortality rate than patients with 45 < ARD <= 50 mm or with ARD > 50 mm (P = 0.004 and P < 0.001, respectively). Heart failure symptoms were associated with a worse outcome (P = 0.041), while the presence of extracardiac involvement had a protective effect (P < 0.001). Conclusion: MFS-related aortopathy is associated with high morbidity rates. In the overall population, an ARD > 45 mm at the time of diagnosis was associated with higher mortality during follow-up.